Keywords: remune, combo, trial, agouron, pharmaceuticals, immune, response

Remune combo trial

Article | 27 September 1999

Print This

Agouron Pharmaceuticals and Immune Response Corp have started a pivotaltrial to evaluate the safety and efficacy of Remune (gp120-depleted ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in